1 |
Boshrouyeh R, Amari S, Boshrouyeh Ghandashtani M, Alavi SE, Ebrahimi Shahmabadi H. A topical gel nanoformulation of amphotericin B (AmB) for the treatment of cutaneous leishmaniasis (CL). J Sol-Gel Sci Technol 2023. [DOI: 10.1007/s10971-023-06041-w] [Reference Citation Analysis]
|
2 |
Ghaferi M, Raza A, Koohi M, Zahra W, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics 2022;14:2183. [DOI: 10.3390/pharmaceutics14102183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Ioele G, Chieffallo M, Occhiuzzi MA, De Luca M, Garofalo A, Ragno G, Grande F. Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties. Molecules 2022;27:5436. [DOI: 10.3390/molecules27175436] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
4 |
Alavi SE, Bakht U, Koohi Moftakhari Esfahani M, Adelnia H, Abdollahi SH, Ebrahimi Shahmabadi H, Raza A. A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics. Pharmaceutics 2022;14:1668. [DOI: 10.3390/pharmaceutics14081668] [Reference Citation Analysis]
|